Eosinophilic Esophagitis research hub

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

This study is looking at a new medicine called Tezepelumab for people aged 12-80 with Eosinophilic Oesophagitis (EoE). It aims to see if regular injections help improve symptoms and is safe, compared to a dummy treatment.

Capsule Sponge Study in Eosinophilic Oesophagitis

This study looks at using a 'capsule sponge' to check how well treatment for Eosinophilic Oesophagitis (EoE) is working. It aims to see if this simpler test can replace gastroscopy for adults with EoE, and if patients prefer it.

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

This study is testing a new treatment, EP-104GI, for adults with eosinophilic esophagitis (EoE). It aims to see if it's safe, how well it works, and how the body handles it. Participants will either receive the treatment or a dummy version.

"A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS"

CDX0159-08: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The “EvolvE” Study)